Company profile

Calendar

13 Aug 20
30 Sep 20

News

Quarter (USD) Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
25 Sep 20 Peter A. Kadens Subordinate Voting Shares Sell Dispose S No 12.35 50,000 617.5K 303,886
25 Sep 20 Peter A. Kadens Subordinate Voting Shares Sell Dispose S No 12.24 100,000 1.22M 353,886
25 Sep 20 Peter A. Kadens Subordinate Voting Shares Sell Dispose S No 12.01 100,000 1.2M 453,886
15 Sep 20 Peter A. Kadens Subordinate Voting Shares Gift Aquire G No 0 35,000 0 35,000
15 Sep 20 Peter A. Kadens Subordinate Voting Shares Gift Dispose G No 0 35,000 0 553,886
1 Sep 20 Gruver William R Subordinate Voting Shares Grant Aquire A No 0 16,700 0 38,539
1 Sep 20 Yemenidjian Alex Subordinate Voting Shares Grant Aquire A No 0 4,217 0 22,416
1 Sep 20 Moore Westley Subordinate Voting Shares Grant Aquire A No 0 4,217 0 155,217

Financial report summary

?
Competition
Medicine Man
Management Discussion
  • The Company has consolidated financial statements across its operating businesses with revenue from the manufacture, sale and distribution of branded cannabis products to third-party retail customers as well as the sale of finished products to consumers in its retail stores.
  • As of the year ended December 31, 2019, GTI has operating revenue in all of its 12 markets (California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New Jersey, New York, Ohio and Pennsylvania).
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg